This opportunity is no longer accepting applications.
grant RFA-DA-23-056

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

This grant opportunity supports groundbreaking research aimed at understanding and reversing the effects of overdoses caused by ultra-potent synthetic opioids. It focuses on identifying key mechanisms, signaling pathways, and potential therapeutic targets. Additionally, it supports studies on the long-term or delayed health effects following acute exposure to these opioids.

This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) o…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Awards & funding

Award Ceiling: $300,000
Award Amount: $300,000

Dates

Opportunity Released: August 17, 2022
Open for Submission: August 17, 2022
Submission Deadline: November 19, 2024
Application Window Closes: November 19, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.